Argent Biopharma Ltd logo

Argent Biopharma Ltd

NEW
OTCPK:RGTLF (Australia)  
$ 0.058 (0%) 12:08 AM EST
At Loss
Enterprise V:
$ 11.41M
Volume:
-
Avg Vol (2M):
657.00
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
-
At Loss
Avg Vol (2M):
657.00

Business Description

Description
Argent Biopharma Ltd is a drug discovery company that addresses unmet medical needs. The company focuses on multidisciplinary methods with nanotechnology, developing multi-target therapies for comprehensive disease management, especially in the central nervous system and immunology treatments. The products of the company include CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury, and ARDS, and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development, and others.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -3.56
Debt-to-Equity -0.86
Debt-to-EBITDA -0.44
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -22.67
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.16
Quick Ratio 0.13
Cash Ratio 0.05
Days Inventory 1804.23
Days Sales Outstanding 409.87
Days Payable 5935.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -169.2
Shareholder Yield % -104.77

Financials (Next Earnings Date:2025-08-29 Est.)

RGTLF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RGTLF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Argent Biopharma Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.189
EPS (TTM) ($) -0.305
Beta -1.76
3-Year Sharpe Ratio -0.91
3-Year Sortino Ratio -1.21
Volatility % 148.85
14-Day RSI 9.09
14-Day ATR ($) 0.00217
20-Day SMA ($) 0.0577
12-1 Month Momentum % -79.75
52-Week Range ($) 0.0577 - 0.5683
Shares Outstanding (Mil) 59.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Argent Biopharma Ltd Filings

Filing Date Document Date Form
No Filing Data

Argent Biopharma Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Argent Biopharma Ltd Frequently Asked Questions

What is Argent Biopharma Ltd(RGTLF)'s stock price today?
The current price of RGTLF is $0.06. The 52 week high of RGTLF is $0.57 and 52 week low is $0.06.
When is next earnings date of Argent Biopharma Ltd(RGTLF)?
The next earnings date of Argent Biopharma Ltd(RGTLF) is 2025-08-29 Est..
Does Argent Biopharma Ltd(RGTLF) pay dividends? If so, how much?
Argent Biopharma Ltd(RGTLF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1